🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04227002
Recruiting Observational

Hamburg AoRtic Valve cOhoRt

NCT04227002 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-09-01
Last updated
2020-01-13

Condition(s) studied

Aortic Valve Stenosis

Study summary

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis) * Written informed consent Exclusion Criteria: * Insufficient knowledge of the German language (able to understand and write the German language) * Physical or psychological incapability to take part in the investigation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitäres Herz- und Gefäßzentrum Hamburg Germany Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04227002 on ClinicalTrials.gov ↗ ← All trials in Germany